Literature DB >> 16305590

Usage of paracetamol-containing combination analgesics remains high in primary care.

Cara Usher1, Mary Teeling, Kathleen Bennett, Bernie McGowan, John Feely.   

Abstract

AIMS: Paracetamol-containing combination analgesics are widely prescribed but the use of paracetamol/dextropropoxyphene (co-proxamol) is particularly controversial. We aim to examine the prescribing patterns of the paracetamol-containing analgesics in Ireland.
METHODS: A national primary care prescribing database was used to investigate patterns of usage. Twenty-six thousand three hundred and eighteen patients who were new to therapy with paracetamol and paracetamol-containing analgesics between January and June 2002 were identified as follows: no previous analgesic medication in the 6 months prior to enrolment into the study, and followed up for at least 12 months from the time of enrolment. Duration of therapy and the number of prescriptions received post enrolment were analyzed according to age. Odds ratios for receiving long-term (>1 month) compared with short-term (1 month) prescriptions for co-proxamol, paracetamol only or a paracetamol combination-type analgesic were calculated for women vs. men, and in those aged over 65 vs. those aged under 65 years.
RESULTS: Co-proxamol was the most commonly prescribed analgesic, accounting for 42% of all prescriptions dispensed during 2003. Long-term use of paracetamol-containing analgesic preparations was uncommon, with 56.7% receiving only 1 month's prescription during the study period. However, women (OR = 1.18, 95% CI 1.07, 1.28, P < 0.0001) and those over 65 years (OR = 1.71, 95% CI 1.57, 1.86, P < 0.0001) were more likely to receive a follow-up prescription for co-proxamol, but also for paracetamol (women, OR = 1.28, 95% CI 1.16, 1.39; over 65 year olds, OR = 2.67, 95% CI 2.44, 2.93) and the paracetamol combinations (women, OR = 1.33, 95% CI 1.20, 1.47; over 65 year olds, OR = 1.69, 95% CI 1.53, 1.87).
CONCLUSIONS: Co-proxamol was the most commonly prescribed paracetamol-containing analgesic preparation in Ireland. The results may indicate inappropriate use in primary care.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16305590      PMCID: PMC1884892          DOI: 10.1111/j.1365-2125.2005.02500.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  19 in total

1.  Development and validation of an improving prescribing in the elderly tool.

Authors:  C T Naugler; C Brymer; P Stolee; Z A Arcese
Journal:  Can J Clin Pharmacol       Date:  2000

2.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.

Authors:  Donna M Fick; James W Cooper; William E Wade; Jennifer L Waller; J Ross Maclean; Mark H Beers
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

3.  Co-proxamol and suicide: Licence needs to be changed.

Authors:  D N Bateman; R Afshari
Journal:  BMJ       Date:  2003-08-02

4.  Co-proxamol and suicide: Co-proxamol should be restricted, not banned.

Authors:  Ivan L Marples
Journal:  BMJ       Date:  2003-08-02

5.  The application of prescribing indicators to a primary care prescription database in Ireland.

Authors:  D Williams; K Bennett; J Feely
Journal:  Eur J Clin Pharmacol       Date:  2005-02-12       Impact factor: 2.953

6.  Distalgesic and its equivalents: time for action.

Authors: 
Journal:  Drug Ther Bull       Date:  1983-03-11

7.  Co-proxamol and suicide: Availability of co-proxamol has been successfully reduced in Doncaster.

Authors:  Paul T Fryers; Michael Geraghty; Christine Hall
Journal:  BMJ       Date:  2003-08-02

8.  Dextropropoxyphene deaths: coroner's report.

Authors:  R M Whittington
Journal:  Hum Toxicol       Date:  1984-08

9.  Co-proxamol and suicide: a study of national mortality statistics and local non-fatal self poisonings.

Authors:  Keith Hawton; Sue Simkin; Jonathan Deeks
Journal:  BMJ       Date:  2003-05-10

10.  Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care.

Authors:  David Williams; Kathleen Bennett; John Feely
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335

View more
  2 in total

1.  UV-induced photocatalytic degradation of aqueous acetaminophen: the role of adsorption and reaction kinetics.

Authors:  Shaik Basha; David Keane; Kieran Nolan; Michael Oelgemöller; Jenny Lawler; John M Tobin; Anne Morrissey
Journal:  Environ Sci Pollut Res Int       Date:  2014-08-31       Impact factor: 4.223

2.  Hypokalaemia and Renal Tubular Acidosis due to Abuse of Nurofen Plus.

Authors:  M J Blackstock; A Lee
Journal:  Case Rep Crit Care       Date:  2012-08-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.